Axsome Therapeutics (AXSM) - Momentum Movers

Axsome Therapeutics (AXSM) – Momentum Movers

Nov 28, 2022 09:12 AM Axsome Therapeutics (AXSM) Climbs 20% After AXS-05 Hits Primary Endpoint in the ACCORD Phase 3 Trial in AD Agitation
Aug 19, 2022 07:23 AM Axsome Therapeutics (AXSM) Climbs 40% Following FDA Approval of AUVELITY
Jun 27, 2022 07:24 AM
Apr 25, 2022 08:29 AM
Apr 19, 2022 07:09 AM
Aug 9, 2021 01:33 PM
Apr 27, 2020 09:42 AM
Apr 27, 2020 06:56 AM
Dec 30, 2019 08:55 AM
Dec 16, 2019 01:23 PM
Jan 8, 2019 09:54 AM
Jan 8, 2019 06:28 AM
Jan 7, 2019 11:11 AM
Jan 7, 2019 07:22 AM
Jan 9, 2018 07:34 AM